Sedation for critically ill patients with COVID-19: Which specificities? One size does not fit all.
Identifieur interne : 000641 ( Main/Exploration ); précédent : 000640; suivant : 000642Sedation for critically ill patients with COVID-19: Which specificities? One size does not fit all.
Auteurs : Jean-François Payen [France] ; Gérald Chanques [France] ; Emmanuel Futier [France] ; Lionel Velly [France] ; Samir Jaber [France] ; Jean-Michel Constantin [France]Source :
- Anaesthesia, critical care & pain medicine [ 2352-5568 ] ; 2020.
Descripteurs français
- KwdFr :
- Analgésiques morphiniques (administration et posologie), Analgésiques morphiniques (effets indésirables), Analgésiques morphiniques (usage thérapeutique), Association de médicaments (MeSH), Betacoronavirus (MeSH), Compliance pulmonaire (effets des médicaments et des substances chimiques), Curarisants (administration et posologie), Curarisants (effets indésirables), Curarisants (usage thérapeutique), Douleur liée aux interventions (prévention et contrôle), Douleur liée aux interventions (traitement médicamenteux), Douleur liée aux interventions (étiologie), Délire avec confusion (induit chimiquement), Humains (MeSH), Hypnotiques et sédatifs (administration et posologie), Hypnotiques et sédatifs (effets indésirables), Hypnotiques et sédatifs (ressources et distribution), Hypnotiques et sédatifs (usage thérapeutique), Hémodynamique (effets des médicaments et des substances chimiques), Infections à coronavirus (complications), Lésion pulmonaire induite par la ventilation mécanique (prévention et contrôle), Maladie grave (MeSH), Pandémies (MeSH), Pneumopathie virale (complications), Procédures superflues (MeSH), Propofol (administration et posologie), Propofol (effets indésirables), Propofol (usage thérapeutique), Sevrage de la ventilation mécanique (MeSH), Syndrome de détresse respiratoire de l'adulte (thérapie), Sédation profonde (effets indésirables), Sédation profonde (méthodes), Ventilation artificielle (effets indésirables).
- MESH :
- administration et posologie : Analgésiques morphiniques, Curarisants, Hypnotiques et sédatifs, Propofol.
- effets des médicaments et des substances chimiques : Compliance pulmonaire, Hémodynamique.
- effets indésirables : Analgésiques morphiniques, Curarisants, Hypnotiques et sédatifs, Infections à coronavirus, Pneumopathie virale, Propofol, Sédation profonde, Ventilation artificielle.
- induit chimiquement : Délire avec confusion.
- méthodes : Sédation profonde.
- prévention et contrôle : Douleur liée aux interventions, Lésion pulmonaire induite par la ventilation mécanique.
- ressources et distribution : Hypnotiques et sédatifs.
- thérapie : Syndrome de détresse respiratoire de l'adulte.
- traitement médicamenteux : Douleur liée aux interventions.
- usage thérapeutique : Analgésiques morphiniques, Curarisants, Hypnotiques et sédatifs, Propofol.
- étiologie : Douleur liée aux interventions.
- Association de médicaments, Betacoronavirus, Humains, Maladie grave, Pandémies, Procédures superflues, Sevrage de la ventilation mécanique.
English descriptors
- KwdEn :
- Analgesics, Opioid (administration & dosage), Analgesics, Opioid (adverse effects), Analgesics, Opioid (therapeutic use), Betacoronavirus (MeSH), Coronavirus Infections (complications), Critical Illness (MeSH), Deep Sedation (adverse effects), Deep Sedation (methods), Delirium (chemically induced), Drug Therapy, Combination (MeSH), Hemodynamics (drug effects), Humans (MeSH), Hypnotics and Sedatives (administration & dosage), Hypnotics and Sedatives (adverse effects), Hypnotics and Sedatives (supply & distribution), Hypnotics and Sedatives (therapeutic use), Lung Compliance (drug effects), Neuromuscular Blocking Agents (administration & dosage), Neuromuscular Blocking Agents (adverse effects), Neuromuscular Blocking Agents (therapeutic use), Pain, Procedural (drug therapy), Pain, Procedural (etiology), Pain, Procedural (prevention & control), Pandemics (MeSH), Pneumonia, Viral (complications), Propofol (administration & dosage), Propofol (adverse effects), Propofol (therapeutic use), Respiration, Artificial (adverse effects), Respiratory Distress Syndrome, Adult (therapy), Unnecessary Procedures (MeSH), Ventilator Weaning (MeSH), Ventilator-Induced Lung Injury (prevention & control).
- MESH :
- chemical , administration & dosage : Analgesics, Opioid, Hypnotics and Sedatives, Neuromuscular Blocking Agents, Propofol.
- chemical , adverse effects : Analgesics, Opioid, Hypnotics and Sedatives, Neuromuscular Blocking Agents, Propofol.
- chemical , supply & distribution : Hypnotics and Sedatives.
- chemical , therapeutic use : Analgesics, Opioid, Hypnotics and Sedatives, Neuromuscular Blocking Agents, Propofol.
- adverse effects : Deep Sedation, Respiration, Artificial.
- chemically induced : Delirium.
- complications : Coronavirus Infections, Pneumonia, Viral.
- drug effects : Hemodynamics, Lung Compliance.
- drug therapy : Pain, Procedural.
- etiology : Pain, Procedural.
- methods : Deep Sedation.
- prevention & control : Pain, Procedural, Ventilator-Induced Lung Injury.
- therapy : Respiratory Distress Syndrome, Adult.
- Betacoronavirus, Critical Illness, Drug Therapy, Combination, Humans, Pandemics, Unnecessary Procedures, Ventilator Weaning.
DOI: 10.1016/j.accpm.2020.04.010
PubMed: 32360979
PubMed Central: PMC7189860
Affiliations:
- France
- Auvergne (région administrative), Auvergne-Rhône-Alpes, Languedoc-Roussillon, Occitanie (région administrative), Provence-Alpes-Côte d'Azur, Rhône-Alpes, Île-de-France
- Clermont-Ferrand, Grenoble, Marseille, Montpellier, Paris
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Sedation for critically ill patients with COVID-19: Which specificities? One size does not fit all.</title>
<author><name sortKey="Payen, Jean Francois" sort="Payen, Jean Francois" uniqKey="Payen J" first="Jean-François" last="Payen">Jean-François Payen</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Anaesthesia and Intensive Care, Grenoble-Alpes University Hospital, and Grenoble-Alpes University, Grenoble Institut des Neurosciences, INSERM U1216, 38000 Grenoble, France. Electronic address: jfpayen@univ-grenoble-alpes.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Anaesthesia and Intensive Care, Grenoble-Alpes University Hospital, and Grenoble-Alpes University, Grenoble Institut des Neurosciences, INSERM U1216, 38000 Grenoble</wicri:regionArea>
<placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
<settlement type="city">Grenoble</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chanques, Gerald" sort="Chanques, Gerald" uniqKey="Chanques G" first="Gérald" last="Chanques">Gérald Chanques</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Anaesthesia and Intensive Care, University of Montpellier Saint-Éloi Hospital, and PhyMedExp, University of Montpellier, INSERM, CNRS, 34295 Montpellier cedex 5, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Anaesthesia and Intensive Care, University of Montpellier Saint-Éloi Hospital, and PhyMedExp, University of Montpellier, INSERM, CNRS, 34295 Montpellier cedex 5</wicri:regionArea>
<placeName><region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
<settlement type="city">Montpellier</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Futier, Emmanuel" sort="Futier, Emmanuel" uniqKey="Futier E" first="Emmanuel" last="Futier">Emmanuel Futier</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Anaesthesia and Intensive Care, Estaing Hospital, and Université Clermont-Auvergne, CNRS, INSERM U-1103, 63000 Clermont-Ferrand, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Anaesthesia and Intensive Care, Estaing Hospital, and Université Clermont-Auvergne, CNRS, INSERM U-1103, 63000 Clermont-Ferrand</wicri:regionArea>
<placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Auvergne (région administrative)</region>
<settlement type="city">Clermont-Ferrand</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Velly, Lionel" sort="Velly, Lionel" uniqKey="Velly L" first="Lionel" last="Velly">Lionel Velly</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Anaesthesiology and Critical Care Medicine, Aix-Marseille University, AP-HM, University Hospital La Timone, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Anaesthesiology and Critical Care Medicine, Aix-Marseille University, AP-HM, University Hospital La Timone, Marseille</wicri:regionArea>
<placeName><region type="region">Provence-Alpes-Côte d'Azur</region>
<region type="old region">Provence-Alpes-Côte d'Azur</region>
<settlement type="city">Marseille</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jaber, Samir" sort="Jaber, Samir" uniqKey="Jaber S" first="Samir" last="Jaber">Samir Jaber</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Anaesthesia and Intensive Care, University of Montpellier Saint-Éloi Hospital, and PhyMedExp, University of Montpellier, INSERM, CNRS, 34295 Montpellier cedex 5, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Anaesthesia and Intensive Care, University of Montpellier Saint-Éloi Hospital, and PhyMedExp, University of Montpellier, INSERM, CNRS, 34295 Montpellier cedex 5</wicri:regionArea>
<placeName><region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
<settlement type="city">Montpellier</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Constantin, Jean Michel" sort="Constantin, Jean Michel" uniqKey="Constantin J" first="Jean-Michel" last="Constantin">Jean-Michel Constantin</name>
<affiliation wicri:level="3"><nlm:affiliation>Sorbonne University, GRC 29, AP-HP, DMU DREAM, and Department of Anaesthesiology and Critical Care, Pitié-Salpêtrière Hospital, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Sorbonne University, GRC 29, AP-HP, DMU DREAM, and Department of Anaesthesiology and Critical Care, Pitié-Salpêtrière Hospital, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32360979</idno>
<idno type="pmid">32360979</idno>
<idno type="doi">10.1016/j.accpm.2020.04.010</idno>
<idno type="pmc">PMC7189860</idno>
<idno type="wicri:Area/Main/Corpus">001473</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001473</idno>
<idno type="wicri:Area/Main/Curation">001473</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001473</idno>
<idno type="wicri:Area/Main/Exploration">001473</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Sedation for critically ill patients with COVID-19: Which specificities? One size does not fit all.</title>
<author><name sortKey="Payen, Jean Francois" sort="Payen, Jean Francois" uniqKey="Payen J" first="Jean-François" last="Payen">Jean-François Payen</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Anaesthesia and Intensive Care, Grenoble-Alpes University Hospital, and Grenoble-Alpes University, Grenoble Institut des Neurosciences, INSERM U1216, 38000 Grenoble, France. Electronic address: jfpayen@univ-grenoble-alpes.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Anaesthesia and Intensive Care, Grenoble-Alpes University Hospital, and Grenoble-Alpes University, Grenoble Institut des Neurosciences, INSERM U1216, 38000 Grenoble</wicri:regionArea>
<placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
<settlement type="city">Grenoble</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chanques, Gerald" sort="Chanques, Gerald" uniqKey="Chanques G" first="Gérald" last="Chanques">Gérald Chanques</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Anaesthesia and Intensive Care, University of Montpellier Saint-Éloi Hospital, and PhyMedExp, University of Montpellier, INSERM, CNRS, 34295 Montpellier cedex 5, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Anaesthesia and Intensive Care, University of Montpellier Saint-Éloi Hospital, and PhyMedExp, University of Montpellier, INSERM, CNRS, 34295 Montpellier cedex 5</wicri:regionArea>
<placeName><region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
<settlement type="city">Montpellier</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Futier, Emmanuel" sort="Futier, Emmanuel" uniqKey="Futier E" first="Emmanuel" last="Futier">Emmanuel Futier</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Anaesthesia and Intensive Care, Estaing Hospital, and Université Clermont-Auvergne, CNRS, INSERM U-1103, 63000 Clermont-Ferrand, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Anaesthesia and Intensive Care, Estaing Hospital, and Université Clermont-Auvergne, CNRS, INSERM U-1103, 63000 Clermont-Ferrand</wicri:regionArea>
<placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Auvergne (région administrative)</region>
<settlement type="city">Clermont-Ferrand</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Velly, Lionel" sort="Velly, Lionel" uniqKey="Velly L" first="Lionel" last="Velly">Lionel Velly</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Anaesthesiology and Critical Care Medicine, Aix-Marseille University, AP-HM, University Hospital La Timone, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Anaesthesiology and Critical Care Medicine, Aix-Marseille University, AP-HM, University Hospital La Timone, Marseille</wicri:regionArea>
<placeName><region type="region">Provence-Alpes-Côte d'Azur</region>
<region type="old region">Provence-Alpes-Côte d'Azur</region>
<settlement type="city">Marseille</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jaber, Samir" sort="Jaber, Samir" uniqKey="Jaber S" first="Samir" last="Jaber">Samir Jaber</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Anaesthesia and Intensive Care, University of Montpellier Saint-Éloi Hospital, and PhyMedExp, University of Montpellier, INSERM, CNRS, 34295 Montpellier cedex 5, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Anaesthesia and Intensive Care, University of Montpellier Saint-Éloi Hospital, and PhyMedExp, University of Montpellier, INSERM, CNRS, 34295 Montpellier cedex 5</wicri:regionArea>
<placeName><region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
<settlement type="city">Montpellier</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Constantin, Jean Michel" sort="Constantin, Jean Michel" uniqKey="Constantin J" first="Jean-Michel" last="Constantin">Jean-Michel Constantin</name>
<affiliation wicri:level="3"><nlm:affiliation>Sorbonne University, GRC 29, AP-HP, DMU DREAM, and Department of Anaesthesiology and Critical Care, Pitié-Salpêtrière Hospital, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Sorbonne University, GRC 29, AP-HP, DMU DREAM, and Department of Anaesthesiology and Critical Care, Pitié-Salpêtrière Hospital, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Anaesthesia, critical care & pain medicine</title>
<idno type="eISSN">2352-5568</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Analgesics, Opioid (administration & dosage)</term>
<term>Analgesics, Opioid (adverse effects)</term>
<term>Analgesics, Opioid (therapeutic use)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Coronavirus Infections (complications)</term>
<term>Critical Illness (MeSH)</term>
<term>Deep Sedation (adverse effects)</term>
<term>Deep Sedation (methods)</term>
<term>Delirium (chemically induced)</term>
<term>Drug Therapy, Combination (MeSH)</term>
<term>Hemodynamics (drug effects)</term>
<term>Humans (MeSH)</term>
<term>Hypnotics and Sedatives (administration & dosage)</term>
<term>Hypnotics and Sedatives (adverse effects)</term>
<term>Hypnotics and Sedatives (supply & distribution)</term>
<term>Hypnotics and Sedatives (therapeutic use)</term>
<term>Lung Compliance (drug effects)</term>
<term>Neuromuscular Blocking Agents (administration & dosage)</term>
<term>Neuromuscular Blocking Agents (adverse effects)</term>
<term>Neuromuscular Blocking Agents (therapeutic use)</term>
<term>Pain, Procedural (drug therapy)</term>
<term>Pain, Procedural (etiology)</term>
<term>Pain, Procedural (prevention & control)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (complications)</term>
<term>Propofol (administration & dosage)</term>
<term>Propofol (adverse effects)</term>
<term>Propofol (therapeutic use)</term>
<term>Respiration, Artificial (adverse effects)</term>
<term>Respiratory Distress Syndrome, Adult (therapy)</term>
<term>Unnecessary Procedures (MeSH)</term>
<term>Ventilator Weaning (MeSH)</term>
<term>Ventilator-Induced Lung Injury (prevention & control)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Analgésiques morphiniques (administration et posologie)</term>
<term>Analgésiques morphiniques (effets indésirables)</term>
<term>Analgésiques morphiniques (usage thérapeutique)</term>
<term>Association de médicaments (MeSH)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Compliance pulmonaire (effets des médicaments et des substances chimiques)</term>
<term>Curarisants (administration et posologie)</term>
<term>Curarisants (effets indésirables)</term>
<term>Curarisants (usage thérapeutique)</term>
<term>Douleur liée aux interventions (prévention et contrôle)</term>
<term>Douleur liée aux interventions (traitement médicamenteux)</term>
<term>Douleur liée aux interventions (étiologie)</term>
<term>Délire avec confusion (induit chimiquement)</term>
<term>Humains (MeSH)</term>
<term>Hypnotiques et sédatifs (administration et posologie)</term>
<term>Hypnotiques et sédatifs (effets indésirables)</term>
<term>Hypnotiques et sédatifs (ressources et distribution)</term>
<term>Hypnotiques et sédatifs (usage thérapeutique)</term>
<term>Hémodynamique (effets des médicaments et des substances chimiques)</term>
<term>Infections à coronavirus (complications)</term>
<term>Lésion pulmonaire induite par la ventilation mécanique (prévention et contrôle)</term>
<term>Maladie grave (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (complications)</term>
<term>Procédures superflues (MeSH)</term>
<term>Propofol (administration et posologie)</term>
<term>Propofol (effets indésirables)</term>
<term>Propofol (usage thérapeutique)</term>
<term>Sevrage de la ventilation mécanique (MeSH)</term>
<term>Syndrome de détresse respiratoire de l'adulte (thérapie)</term>
<term>Sédation profonde (effets indésirables)</term>
<term>Sédation profonde (méthodes)</term>
<term>Ventilation artificielle (effets indésirables)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Analgesics, Opioid</term>
<term>Hypnotics and Sedatives</term>
<term>Neuromuscular Blocking Agents</term>
<term>Propofol</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Analgesics, Opioid</term>
<term>Hypnotics and Sedatives</term>
<term>Neuromuscular Blocking Agents</term>
<term>Propofol</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="supply & distribution" xml:lang="en"><term>Hypnotics and Sedatives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Analgesics, Opioid</term>
<term>Hypnotics and Sedatives</term>
<term>Neuromuscular Blocking Agents</term>
<term>Propofol</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Analgésiques morphiniques</term>
<term>Curarisants</term>
<term>Hypnotiques et sédatifs</term>
<term>Propofol</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Deep Sedation</term>
<term>Respiration, Artificial</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Delirium</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Hemodynamics</term>
<term>Lung Compliance</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Pain, Procedural</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr"><term>Compliance pulmonaire</term>
<term>Hémodynamique</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Analgésiques morphiniques</term>
<term>Curarisants</term>
<term>Hypnotiques et sédatifs</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Propofol</term>
<term>Sédation profonde</term>
<term>Ventilation artificielle</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Pain, Procedural</term>
</keywords>
<keywords scheme="MESH" qualifier="induit chimiquement" xml:lang="fr"><term>Délire avec confusion</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Deep Sedation</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Sédation profonde</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Pain, Procedural</term>
<term>Ventilator-Induced Lung Injury</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Douleur liée aux interventions</term>
<term>Lésion pulmonaire induite par la ventilation mécanique</term>
</keywords>
<keywords scheme="MESH" qualifier="ressources et distribution" xml:lang="fr"><term>Hypnotiques et sédatifs</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Respiratory Distress Syndrome, Adult</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Syndrome de détresse respiratoire de l'adulte</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Douleur liée aux interventions</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Analgésiques morphiniques</term>
<term>Curarisants</term>
<term>Hypnotiques et sédatifs</term>
<term>Propofol</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Douleur liée aux interventions</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term>
<term>Critical Illness</term>
<term>Drug Therapy, Combination</term>
<term>Humans</term>
<term>Pandemics</term>
<term>Unnecessary Procedures</term>
<term>Ventilator Weaning</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Association de médicaments</term>
<term>Betacoronavirus</term>
<term>Humains</term>
<term>Maladie grave</term>
<term>Pandémies</term>
<term>Procédures superflues</term>
<term>Sevrage de la ventilation mécanique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32360979</PMID>
<DateCompleted><Year>2020</Year>
<Month>07</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>08</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-5568</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>39</Volume>
<Issue>3</Issue>
<PubDate><Year>2020</Year>
<Month>06</Month>
</PubDate>
</JournalIssue>
<Title>Anaesthesia, critical care & pain medicine</Title>
<ISOAbbreviation>Anaesth Crit Care Pain Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Sedation for critically ill patients with COVID-19: Which specificities? One size does not fit all.</ArticleTitle>
<Pagination><MedlinePgn>341-343</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S2352-5568(20)30077-1</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.accpm.2020.04.010</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Payen</LastName>
<ForeName>Jean-François</ForeName>
<Initials>JF</Initials>
<AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Grenoble-Alpes University Hospital, and Grenoble-Alpes University, Grenoble Institut des Neurosciences, INSERM U1216, 38000 Grenoble, France. Electronic address: jfpayen@univ-grenoble-alpes.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chanques</LastName>
<ForeName>Gérald</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, University of Montpellier Saint-Éloi Hospital, and PhyMedExp, University of Montpellier, INSERM, CNRS, 34295 Montpellier cedex 5, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Futier</LastName>
<ForeName>Emmanuel</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Estaing Hospital, and Université Clermont-Auvergne, CNRS, INSERM U-1103, 63000 Clermont-Ferrand, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Velly</LastName>
<ForeName>Lionel</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care Medicine, Aix-Marseille University, AP-HM, University Hospital La Timone, Marseille, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Jaber</LastName>
<ForeName>Samir</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, University of Montpellier Saint-Éloi Hospital, and PhyMedExp, University of Montpellier, INSERM, CNRS, 34295 Montpellier cedex 5, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Constantin</LastName>
<ForeName>Jean-Michel</ForeName>
<Initials>JM</Initials>
<AffiliationInfo><Affiliation>Sorbonne University, GRC 29, AP-HP, DMU DREAM, and Department of Anaesthesiology and Critical Care, Pitié-Salpêtrière Hospital, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>04</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>France</Country>
<MedlineTA>Anaesth Crit Care Pain Med</MedlineTA>
<NlmUniqueID>101652401</NlmUniqueID>
<ISSNLinking>2352-5568</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000701">Analgesics, Opioid</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009466">Neuromuscular Blocking Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>YI7VU623SF</RegistryNumber>
<NameOfSubstance UI="D015742">Propofol</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000701" MajorTopicYN="N">Analgesics, Opioid</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016638" MajorTopicYN="Y">Critical Illness</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D054810" MajorTopicYN="N">Deep Sedation</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003693" MajorTopicYN="N">Delirium</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006993" MajorTopicYN="N">Hypnotics and Sedatives</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000600" MajorTopicYN="N">supply & distribution</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008170" MajorTopicYN="N">Lung Compliance</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009466" MajorTopicYN="N">Neuromuscular Blocking Agents</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073818" MajorTopicYN="N">Pain, Procedural</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015742" MajorTopicYN="N">Propofol</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome, Adult</DescriptorName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019564" MajorTopicYN="N">Unnecessary Procedures</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015300" MajorTopicYN="N">Ventilator Weaning</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055397" MajorTopicYN="N">Ventilator-Induced Lung Injury</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">COVID-19</Keyword>
<Keyword MajorTopicYN="Y">Pain</Keyword>
<Keyword MajorTopicYN="Y">Sedation</Keyword>
<Keyword MajorTopicYN="Y">Ventilation</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>04</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>04</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>5</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>7</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>5</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32360979</ArticleId>
<ArticleId IdType="pii">S2352-5568(20)30077-1</ArticleId>
<ArticleId IdType="doi">10.1016/j.accpm.2020.04.010</ArticleId>
<ArticleId IdType="pmc">PMC7189860</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>France</li>
</country>
<region><li>Auvergne (région administrative)</li>
<li>Auvergne-Rhône-Alpes</li>
<li>Languedoc-Roussillon</li>
<li>Occitanie (région administrative)</li>
<li>Provence-Alpes-Côte d'Azur</li>
<li>Rhône-Alpes</li>
<li>Île-de-France</li>
</region>
<settlement><li>Clermont-Ferrand</li>
<li>Grenoble</li>
<li>Marseille</li>
<li>Montpellier</li>
<li>Paris</li>
</settlement>
</list>
<tree><country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Payen, Jean Francois" sort="Payen, Jean Francois" uniqKey="Payen J" first="Jean-François" last="Payen">Jean-François Payen</name>
</region>
<name sortKey="Chanques, Gerald" sort="Chanques, Gerald" uniqKey="Chanques G" first="Gérald" last="Chanques">Gérald Chanques</name>
<name sortKey="Constantin, Jean Michel" sort="Constantin, Jean Michel" uniqKey="Constantin J" first="Jean-Michel" last="Constantin">Jean-Michel Constantin</name>
<name sortKey="Futier, Emmanuel" sort="Futier, Emmanuel" uniqKey="Futier E" first="Emmanuel" last="Futier">Emmanuel Futier</name>
<name sortKey="Jaber, Samir" sort="Jaber, Samir" uniqKey="Jaber S" first="Samir" last="Jaber">Samir Jaber</name>
<name sortKey="Velly, Lionel" sort="Velly, Lionel" uniqKey="Velly L" first="Lionel" last="Velly">Lionel Velly</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000641 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000641 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidFranceV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:32360979 |texte= Sedation for critically ill patients with COVID-19: Which specificities? One size does not fit all. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32360979" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a CovidFranceV1
This area was generated with Dilib version V0.6.37. |